Company / Current Assets
Arcutis Biotherapeutics, Inc. Current Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$411.2M
FY2025
5-year range
$330.4M / $437.4M
FY2021-FY2025
Trend
+22.5%
vs FY2024
Sector context
#132 of 213
Health Care
What the data says
At $411M, Arcutis Biotherapeutics, Inc.'s current assets ranks #132 of 213 in the Health Care sector. Improved from $330M to $411M over the past 2 years.
Based on SEC 10-K filings.
$411M in FY2025 with a 5-year CAGR of +7.0%.
Improved from $330M to $411M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -2.0%
- 5-Year CAGR
- +7.0%
- 10-Year CAGR
- -
Sector benchmark
#132 of 213 in Health CareTop 62% of 213This company $411.2M Sector average $2.5B
▼
-83.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +7.0%, indicating consistent growth.
- In FY2025, current assets increased 22.5% year-over-year.
- Ranks #132 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $411.2M | +22.5% |
| FY2024 | $335.8M | +1.6% |
| FY2023 | $330.4M | -24.5% |
| FY2022 | $437.4M | +8.6% |
| FY2021 | $402.8M | +37.5% |
| FY2020 | $292.8M | +175.0% |
| FY2019 | $106.5M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026